Cargando…
Chemotherapy and Glycemic Control in Patients with Type 2 Diabetes and Cancer: A Comparative Case Analysis
OBJECTIVE: Individuals with diabetes who develop cancer have a worse 5-year overall survival rate and are more likely to develop an infection and/or be hospitalized when compared to those without diabetes. Patients with diabetes and cancer receiving chemotherapy have an increased risk for developing...
Autores principales: | Hershey, Denise Soltow, Hession, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473094/ https://www.ncbi.nlm.nih.gov/pubmed/28695169 http://dx.doi.org/10.4103/apjon.apjon_22_17 |
Ejemplares similares
-
Importance of Glycemic Control in Cancer Patients with Diabetes: Treatment through End of Life
por: Hershey, Denise Soltow
Publicado: (2017) -
Longitudinal Analysis of Depressive Symptoms and Glycemic Control in Type 2 Diabetes
por: Aikens, James E., et al.
Publicado: (2009) -
Depression, glycemic control and type 2 diabetes
por: Papelbaum, Marcelo, et al.
Publicado: (2011) -
Effects of metformin extended release compared to immediate release formula on glycemic control and glycemic variability in patients with type 2 diabetes
por: Derosa, Giuseppe, et al.
Publicado: (2017) -
Chronotype preference and glycemic control in type 2 diabetes
por: Xue, Pei, et al.
Publicado: (2021)